WEDNESDAY, Sept. 20, 2023 (HealthDay News) — In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy nasal spray was widely anticipated. An FDA advisory panel votedContinue Reading

WEDNESDAY, Sept. 20, 2023 (HealthDay News) — A deadly infection associated with hospitalization may not be the fault of the hospital, but may instead stem from the patients themselves, a new study suggests. Infection caused by the bacterium Clostridioides difficile, or C. diff, is still common in hospitals, despite extensiveContinue Reading

WEDNESDAY, Sept. 20, 2023 (HealthDay News) — Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are the same as its medication. This time, it’s Eli Lilly suing certain medical spas, wellness centers and compounding pharmacies overContinue Reading